Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03737981
Brief Title: Testing The Addition of a New Anti-cancer Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Obinutuzumab) in Untreated, Older Patients With Chronic Lymphocytic Leukemia

First Submitted : November 9, 2018
First Submitted that Met QC Criteria : November 9, 2018
First Posted : November 13, 2018

Last Update Submitted that Met QC Criteria : July 22, 2021
Last Update Posted : July 23, 2021 (Estimate)